← Back to headlines
Merck & Co. to acquire Terns Pharma for $6.7 billion
Pharmaceutical giant Merck & Co. has announced its intention to acquire Terns Pharma in a deal valued at $6.7 billion. This acquisition is expected to expand Merck's portfolio.
28 Mar, 20:55 — 28 Mar, 20:55
Sources
Showing 1 of 1 sources
